Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 15 Mar 2023 14:25 CET |
ARGENX SE | argenx Announces UK MHRA Approval of VYVGART for the Treatment of Generalized Myasthenia Gravis | 20103010 Biotechnology | Other subject |
| 02 Mar 2023 07:00 CET |
ARGENX SE | argenx Reports Full Year 2022 Financial Results and Provides Fourth Quarter Business Update | 20103010 Biotechnology | Other subject |
| 02 Mar 2023 07:00 CET |
ARGENX SE | argenx Announces Planned Transition of Chief Operating Officer | 20103010 Biotechnology | Other subject |